Panbela Therapeutics Beta
Qual é o Beta de Panbela Therapeutics?
O Beta de Panbela Therapeutics Inc. é 1.27
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em NASDAQ em comparação com Panbela Therapeutics
O que Panbela Therapeutics faz?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas com beta semelhantes a Panbela Therapeutics
- Golden Valley Mines tem Beta de 1.27
- Sotera Health Co tem Beta de 1.27
- Tribune Publishing tem Beta de 1.27
- Plutus PowerGen Plc tem Beta de 1.27
- Lennar tem Beta de 1.27
- Intu Properties Plc tem Beta de 1.27
- Panbela Therapeutics tem Beta de 1.27
- Hollywood Bowl Plc tem Beta de 1.27
- S&T AG tem Beta de 1.27
- Synertec tem Beta de 1.27
- Hays plc tem Beta de 1.27
- Spark Power tem Beta de 1.27
- Office Properties Income Trust tem Beta de 1.27